Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $414.30 Analyst target: $416.39 Upside: 0.50%
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
See the full interactive analysis & chart →Informational only — not investment advice.